Why the study?
Does HMR 1883 prevent ventricular fibrillation in a conscious dog model?
Population
Conscious dog model
Design
Preclinical
Authors
Loading...
May support cardioselective K(ATP) blockade for VF prevention in ischemia; leaves open human translation.
Does HMR 1883 prevent ventricular fibrillation in a conscious dog model?
HMR 1883 is a cardioselective K(ATP) channel blocker that shows potential as a novel drug candidate for preventing ischemia-induced ventricular fibrillation and sudden cardiac death.
Gögelein et al. (1999) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: